Table 3. Minisequencing results on the 3D-Link™-slides, the mercaptosilane-coated slides, the EZ-RAYS™-slides and the unmodified slides compared with those on the isothiocyanate-coated slides.
SNP | Signal intensitya (arbitrary fluorescence units) | Signal/noiseb | |||||||
|
|
3D-Link™ |
Isothiocyanate |
Mercaptosilanec |
Isothiocyanate |
3D-Link™ |
Isothiocyanate |
Mercaptosilanec |
Isothiocyanate |
AGTR1 1166co | C-allele | 31 000 | 2500 | 21 000 | 8300 | 100 | 50 | 47 | 208 |
A-allele | 310 | 50 | 450 | 40 | |||||
AGTR1 1166nc | G-allele | 12 000 | 280 | 9300 | 10 | 24 | 7.0 | 47 | 0.013 |
T-allele | 500 | 40 | 200 | 780 | |||||
AGTR1 1062co | A-allele | 19 000 | 1400 | 21 000 | 7000 | 5.1 | 11 | 12 | ∞ |
G-allele | 3700 | 130 | 1800 | 0 | |||||
AGTR1 1062nc | T-allele | 27 000 | 3000 | 21 000 | 6900 | 250 | 300 | 46 | 53 |
C-allele | 110 | 10 | 460 | 130 | |||||
eNOSco | G-allele | 62 000 | 3500 | 60 000 | 24 000 | 370 | 88 | 38 | 4.8 |
T-allele | 170 | 40 | 1600 | 5000 | |||||
eNOSnc | C-allele | 7300 | 1200 | 17 000 | 3600 | 12 | 7.1 | 21 | 17 |
|
A-allele |
590 |
170 |
830 |
210 |
|
|
|
|
|
|
EZ-RAYS™ |
Isothiocyanate |
Unmodifiedd |
Isothiocyanate |
EZ-RAYS™ |
Isothiocyanate |
Unmodifiedd |
Isothiocyanate |
eNOSco | G-allele | 50 | 8500 | 6600 | 16 000 | 0.069 | 3.0 | 11 | 36 |
T-allele | 720 | 2800 | 610 | 440 | |||||
eNOSnc | C-allele | 4800 | 8400 | 16 000 | 4100 | 69 | 26 | 7.0 | 32 |
A-allele | 70 | 320 | 2300 | 130 |
aSignal intensity = signal intensity of oligonucleotide spot – average background fluorescence. The average values were calculated from two different reactions using sample 1 as DNA template, which was homozygous at all SNP sites. The laser power was 85% for the 3D-Link™/isothiocyanate comparison and for the mercaptosilane/isothiocyanate comparison. For the other two comparison reactions the laser power was 95%. The pmt gain was 75% for the 3D-Link™/isothiocyanate comparison and 85% for all the other comparison reactions.
bThe signal intensity ratio between the expected and the other possible allele.
cThe AGTR1 1166 nc* oligonucleotide was used for the mercaptosilane-array whereas the isothiocyanate-array had the AGTR1 1166 co oligonucleotide (see Table 22).
dThe oligonucleotide concentration was 15 µM for the unmodified oligonucleotides.